Search Results 291-300 of 17105 for nivolumab
The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. Melanoma In-transit Tissue Bank And Molecular Analysis For Personalized ...
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line ...
Ansell led the clinical trial that resulted in the approval by the U.S. Food and Drug Administration (FDA) of nivolumab (Opdivo) for Hodgkin's lymphoma.
Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...
The purpose of this study is to anayze the usefulness of treatment with nivolumab and ipilimumab in addition to standard of care chemotherapy and radiation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!